{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T15:36:53Z","timestamp":1721489813736},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1477-7525-12-99","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T09:12:30Z","timestamp":1402650750000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy"],"prefix":"10.1186","volume":"12","author":[{"given":"Chris D","family":"Poole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob N\u00f8rgaard","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Strodl","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig J","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"issue":"5","key":"1345_CR1","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1183\/09031936.04.00013904","volume":"24","author":"V Bauchau","year":"2004","unstructured":"Bauchau V, Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004, 24(5):758\u2013764. doi:10.1183\/09031936.04.00013904","journal-title":"Eur Respir J"},{"issue":"5","key":"1345_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.rmed.2003.11.015","volume":"98","author":"R Dahl","year":"2004","unstructured":"Dahl R, Andersen PS, Chivato T, Valovirta E, de Monchy J: National prevalence of respiratory allergic disorders. Respir Med 2004, 98(5):398\u2013403. doi:10.1016\/j.rmed.2003.11.015","journal-title":"Respir Med"},{"issue":"Suppl 8","key":"1345_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1398-9995.2007.01548.x","volume":"62","author":"M Schatz","year":"2007","unstructured":"Schatz M: A survey of the burden of allergic rhinitis in the USA. Allergy 2007, 62(Suppl 8):9\u201316. doi:10.1111\/j.1398\u20139995.2007.01548.x","journal-title":"Allergy"},{"issue":"1","key":"1345_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1076\/opep.11.1.17.26437","volume":"11","author":"AD Pitt","year":"2004","unstructured":"Pitt AD, Smith AF, Lindsell L, Voon LW, Rose PW, Bron AJ: Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004, 11(1):17\u201333. doi:10.1076\/opep.11.1.17.26437","journal-title":"Ophthalmic Epidemiol"},{"key":"1345_CR5","volume-title":"GDP deflators","author":"HM Treasury","year":"2012","unstructured":"HM Treasury: GDP deflators. 2012."},{"issue":"1","key":"1345_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2500\/aap.2007.28.2934","volume":"28","author":"RA Nathan","year":"2007","unstructured":"Nathan RA: The burden of allergic rhinitis. Allergy Asthma Proc 2007, 28(1):3\u20139. doi:10.2500\/aap.2007.28.2934","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"1345_CR7","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1398-9995.2009.02269.x","volume":"65","author":"J Hellgren","year":"2010","unstructured":"Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO: Allergic rhinitis and the common cold--high cost to society. Allergy 2010, 65(6):776\u2013783. doi:10.1111\/j.1398\u20139995.2009.02269.x","journal-title":"Allergy"},{"key":"1345_CR8","volume-title":"Guideline on the clinical development on products for specific immuno- therapy for the treatment of allergic diseases","author":"European Medicines Evaluation Agency","year":"2008","unstructured":"European Medicines Evaluation Agency: Guideline on the clinical development on products for specific immuno- therapy for the treatment of allergic diseases. London: EuroQol Group. (n.d.). EQ-5D-3L Value sets; 2008."},{"issue":"1","key":"1345_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","volume":"127","author":"M Blaiss","year":"2011","unstructured":"Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner DP: Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol 2011, 127(1):64\u201371. 71.e1\u20134. doi:10.1016\/j.jaci.2010.11.034","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1345_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1398-9995.2005.00949.x","volume":"61","author":"R Dahl","year":"2006","unstructured":"Dahl R, Stender A, Rak S: Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006, 61(2):185\u2013190. doi:10.1111\/j.1398\u20139995.2005.00949.x","journal-title":"Allergy"},{"issue":"2","key":"1345_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","volume":"118","author":"R Dahl","year":"2006","unstructured":"Dahl R, Kapp A, Colombo G, de Monchy JGR, Rak S, Emminger W, Durham SR: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006, 118(2):434\u2013440. doi:10.1016\/j.jaci.2006.05.003","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1345_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaci.2007.10.039","volume":"121","author":"R Dahl","year":"2008","unstructured":"Dahl R, Kapp A, Colombo G, De Monchy JGR, Rak S, Emminger W, Durham SR: Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 2008, 121(2):512\u2013518. e2. doi:10.1016\/j.jaci.2007.10.039","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1345_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jaci.2009.10.035","volume":"125","author":"SR Durham","year":"2010","unstructured":"Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JGR, Rak S, Dahl R: Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010, 125(1):131\u2013138. e1\u20137. doi:10.1016\/j.jaci.2009.10.035","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1345_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1398-9995.2009.02238.x","volume":"65","author":"L Fr\u00f8lund","year":"2010","unstructured":"Fr\u00f8lund L, Durham SR, Calderon M, Emminger W, Andersen JS, Rask P, Dahl R: Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life. Allergy 2010, 65(6):753\u2013757. doi:10.1111\/j.1398\u20139995.2009.02238.x","journal-title":"Allergy"},{"issue":"1","key":"1345_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","volume":"127","author":"HS Nelson","year":"2011","unstructured":"Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI: Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. J Allergy Clin Immunol 2011, 127(1):72\u201380. 80.e1\u20132. doi:10.1016\/j.jaci.2010.11.035","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1345_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00019053-200017010-00002","volume":"17","author":"SJ Coons","year":"2000","unstructured":"Coons SJ, Rao S, Keininger DL, Hays RD: A Comparative Review of Generic Quality-of-Life Instruments. Pharmacoeconomics 2000, 17(1):13\u201335. doi:10.2165\/00019053\u2013200017010\u201300002","journal-title":"Pharmacoeconomics"},{"key":"1345_CR17","first-page":"1","volume-title":"EQ-5D-3L User Guide: Basic information on how to use the EQ-5D-3L instrument (The EuroQol Group)","author":"R Rabin","year":"2011","unstructured":"Rabin R, Oemar M, Oppe M: EQ-5D-3L User Guide: Basic information on how to use the EQ-5D-3L instrument. In EQ-5D-3L User Guide: Basic information on how to use the EQ-5D-3L instrument (The EuroQol Group). Rotterdam: EuroQol Group; 2011:1\u201323."},{"issue":"11","key":"1345_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35(11):1095\u20131108. Retrieved from http:\/\/journals.lww.com\/lww-medicalcare\/Abstract\/1997\/11000\/Modeling_Valuations_for_EuroQol_Health_States.2.aspx","journal-title":"Med Care"},{"key":"1345_CR19","volume-title":"EuroQol Group Monographs, Volume 2","author":"A Szende","year":"2006","unstructured":"Szende A, Oppe M, Devlin NJ, Group E: EQ-5D Value Sets: Inventory, Comparative Review and User Guide. In EuroQol Group Monographs, Volume 2. Springer; 2006."},{"issue":"3","key":"1345_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","volume":"129","author":"SR Durham","year":"2012","unstructured":"Durham SR, Emminger W, Kapp A, de Monchy JGR, Rak S, Scadding GK, Dahl R: SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012, 129(3):717\u2013725. e5. doi:10.1016\/j.jaci.2011.12.973","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"1345_CR21","first-page":"327","volume":"43","author":"I-C Huang","year":"2008","unstructured":"Huang I-C, Frangakis C, Atkinson MJ, Willke RJ, Leite WL, Vogel WB, Wu AW: Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health Serv Res 2008, 43(1 Pt 1):327\u2013339. doi:10.1111\/j.1475\u20136773.2007.00745.x","journal-title":"Health Serv Res"},{"issue":"3","key":"1345_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10742-009-0053-3","volume":"9","author":"L Li","year":"2009","unstructured":"Li L, Fu AZ: Some methodological issues with the analysis of preference-based EQ-5D index score. Health Serv Outcomes Res Methodol 2009, 9(3):162\u2013176. doi:10.1007\/s10742\u2013009\u20130053\u20133","journal-title":"Health Serv Outcomes Res Methodol"},{"issue":"4","key":"1345_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1524-4733.2010.00695.x","volume":"13","author":"EM Pullenayegum","year":"2010","unstructured":"Pullenayegum EM, Tarride J-E, Xie F, Goeree R, Gerstein HC, O\u2019Reilly D: Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health J Int Soc Pharmacoecon Outcomes Res 2010, 13(4):487\u2013494. doi:10.1111\/j.1524\u20134733.2010.00695.x","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res"},{"key":"1345_CR24","volume-title":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing","author":"R Core Development Team","year":"2013","unstructured":"R Core Development Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. R Foundation for Statistical Computing; 2013. http:\/\/www.r-project.org"},{"issue":"2","key":"1345_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","volume":"11","author":"JE Brazier","year":"2010","unstructured":"Brazier JE, Yang Y, Tsuchiya A, Rowen DL: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ 2010, 11(2):215\u2013225. doi:10.1007\/s10198\u2013009\u20130168-z","journal-title":"Eur J Health Econ"},{"issue":"3","key":"1345_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jval.2011.12.014","volume":"15","author":"M Hern\u00e1ndez Alava","year":"2012","unstructured":"Hern\u00e1ndez Alava M, Wailoo AJ, Ara R: Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health J Int Soc Pharmacoecon Outcomes Res 2012, 15(3):550\u2013561. doi:10.1016\/j.jval.2011.12.014","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res"},{"issue":"5","key":"1345_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/j.1365-2222.2007.02706.x","volume":"37","author":"C Bachert","year":"2007","unstructured":"Bachert C, Vestenbaek U, Christensen J, Griffiths UK, Poulsen PB: Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective. Clin Exp Allergy 2007, 37(5):772\u2013779. doi:10.1111\/j.1365\u20132222.2007.02706.x","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"1345_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/01.mlr.0000172050.67085.4f","volume":"43","author":"PW Sullivan","year":"2005","unstructured":"Sullivan PW, Lawrence WF, Ghushchyan V: A National Catalog of Preference-Based Scores for Chronic Conditions in the United States. Medical Care 2005, 43(7):736\u2013749. doi:10.1097\/01.mlr.0000172050.67085.4f","journal-title":"Medical Care"},{"issue":"4","key":"1345_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/09286580590967781","volume":"12","author":"AF Smith","year":"2005","unstructured":"Smith AF, Pitt AD, Rodruiguez AE, Alio JL, Marti N, Teus M, Barnes JR: The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting. Ophthalmic Epidemiol 2005, 12(4):233\u2013242. doi:10.1080\/09286580590967781","journal-title":"Ophthalmic Epidemiol"},{"issue":"7","key":"1345_CR30","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1365-2222.2011.03935.x","volume":"42","author":"C Col\u00e1s","year":"2012","unstructured":"Col\u00e1s C, Galera H, A\u00f1ibarro B, Soler R, Navarro A, J\u00e1uregui I, Pel\u00e1ez A: Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy 2012, 42(7):1080\u20131087. doi:10.1111\/j.1365\u20132222.2011.03935.x","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"1345_CR31","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1365-2222.2012.04025.x","volume":"42","author":"J Maspero","year":"2012","unstructured":"Maspero J, Lee BW, Katelaris CH, Potter PC, Cingi C, Lopatin A, Walters RD: Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States. Clin Exp Allergy 2012, 42(12):1684\u20131696. doi:10.1111\/j.1365\u20132222.2012.04025.x","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"1345_CR32","doi-asserted-by":"publisher","first-page":"A276","DOI":"10.1016\/S1098-3015(10)70872-X","volume":"11","author":"D Stull","year":"2008","unstructured":"Stull D, O\u2019Quinn S, Vestenbaek U, Navaratnam P: PRS24 CEILING EFFECTS AND DISCRIMINATION OF TREATMENT BENEFIT FOR PATIENTS WITH LOWER SYMPTOM SEVERITY: MEASUREMENT OF HEALTH UTILITIES IN ALLERGIC RHINITIS. Value in Health 2008, 11(3):A276. doi:10.1016\/S1098\u20133015(10)70872-X","journal-title":"Value in Health"},{"key":"1345_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1034\/j.1398-9995.2002.1o3306.x","volume":"57","author":"E Juniper","year":"2002","unstructured":"Juniper E, Thompson A, Roberts J: Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 2002, 57: 201\u2013206.","journal-title":"Allergy"},{"issue":"4","key":"1345_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1034\/j.1398-9995.2001.00852.x","volume":"56","author":"G Majani","year":"2001","unstructured":"Majani G, Biardini I, Giardini A, Senna GE, Minale P, D\u2019Ulisse S, Canonica W: Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001, 56(4):313\u2013317. doi:10.1034\/j.1398\u20139995.2001.00852.x","journal-title":"Allergy"},{"issue":"4","key":"1345_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jval.2010.09.002","volume":"14","author":"DGT Whitehurst","year":"2011","unstructured":"Whitehurst DGT, Bryan S: Another study showing that two preference-based measures of health-related quality of life (EQ-5D and SF-6D) are not interchangeable But why should we expect them to be? Value in Health 2011, 14(4):531\u2013538. doi:10.1016\/j.jval.2010.09.002","journal-title":"Value in Health"},{"issue":"2","key":"1345_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/0272989X10380925","volume":"31","author":"M Palta","year":"2011","unstructured":"Palta M, Chen H-Y, Kaplan RM, Feeny D, Cherepanov D, Fryback DG: Standard error of measurement of 5 health utility indexes across the range of health for use in estimating reliability and responsiveness. Med Decis Making 2011, 31(2):260\u2013269. doi:10.1177\/0272989X10380925","journal-title":"Med Decis Making"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-12-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:28:26Z","timestamp":1630574906000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-12-99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1186\/1477-7525-12-99","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,13]]},"assertion":[{"value":"16 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"99"}}